Figure 1From: Predictors and outcomes of Mycobacterium tuberculosis bacteremia among patients with HIV and tuberculosis co-infection enrolled in the ACTG A5221 STRIDE study Time-to-first new AIDS-defining illness or death among participants with and without mycobacteremia, ACTG A5221 STRIDE study. Back to article page